Our facts demonstrate that CK18 is constantly expressed in many epithelial cancers, Primarily adenocarcinomas. the two loss of CK18 expression in cancers derived from CK18 favourable precursor cells and neo-expression in malignancies derived from CK18 favourable precursors are generally linked to un